Allspring Global Investments’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$108K Sell
16,092
-928
-5% -$6.24K ﹤0.01% 1579
2025
Q1
$149K Buy
17,020
+5,896
+53% +$51.6K ﹤0.01% 1675
2024
Q4
$192K Sell
11,124
-9,397
-46% -$162K ﹤0.01% 1677
2024
Q3
$328K Sell
20,521
-7,110
-26% -$114K ﹤0.01% 1574
2024
Q2
$394K Buy
27,631
+12,868
+87% +$183K ﹤0.01% 1558
2024
Q1
$209K Buy
14,763
+11,965
+428% +$170K ﹤0.01% 1697
2023
Q4
$42.2K Hold
2,798
﹤0.01% 1898
2023
Q3
$44.2K Buy
+2,798
New +$44.2K ﹤0.01% 2304